• Category: Business
Tarsus to purchase Alkeus Pharmaceuticals
Business

Tarsus to purchase Alkeus Pharmaceuticals

Second planned acquisition includes oral gildeuretinol acetate (ALK-001), a new molecular entity in phase 3 trials for Stargardt disease.
Leadership watch: RxSight, Exonate tap new CEOs; CooperVision, Lumenis, and OSU fill top roles
Business

Leadership watch: RxSight, Exonate tap new CEOs; CooperVision, Lumenis, and OSU fill top roles

Leadership changes are underway in the eyecare space—and we’ve got the latest.
Tarsus acquires iRenix Medical, adds late-stage ocular antiseptic
Business

Tarsus acquires iRenix Medical, adds late-stage ocular antiseptic

Company to initiate a phase 3 trial on IRX-101, an ocular antiseptic alternative to povidone-iodine among retinal patients receiving IVT injections.
Leadership watch: Optos, Bascom Palmer, and AOA share updates
Business

Leadership watch: Optos, Bascom Palmer, and AOA share updates

Leadership changes are underway in the eyecare space—and we’ve got the latest.
Carrot expands VR diagnostics with real-time analytics dashboard
Business

Carrot expands VR diagnostics with real-time analytics dashboard

Diagnostics and operational platform tracks performance, uncovers missed revenue, and optimizes clinical workflows across providers and locations.
Visionix and iCare officially merge portfolios
Business

Visionix and iCare officially merge portfolios

Integration follows after parent company Revenio announced plans to combine both arsenals of ophthalmic medical device and imaging solutions.
Leadership watch: Optivate, TVC, Ocuco name new executives
Business

Leadership watch: Optivate, TVC, Ocuco name new executives

Leadership changes are underway in the eyecare space—and we’ve got the latest.
National Academy of Opticianry and United Opticians Association kick-start potential merger
Business

National Academy of Opticianry and United Opticians Association kick-start potential merger

Announcement follows both organizations’ vote to authorize a formal process last week; next phase involves review by a joint steering committee.
Lexitas acquires Erie Retina Research to expand ophthalmic trials
Business

Lexitas acquires Erie Retina Research to expand ophthalmic trials

Partnership also involves integration of CASExERIE and Element Erie: Imaging and Reading Center to establish a fully integrated retina research platform.
NeuroVision expands retinal imaging-based neurodegenerative disease detection with new acquisition
Business

NeuroVision expands retinal imaging-based neurodegenerative disease detection with new acquisition

Retinal imaging developer adds Durin Life Sciences’ noninvasive, blood-based biomarker test to its integrated platform targeting cognitive diseases.
Myopia Focus launches customizable patient education tools for ECP websites
Business

Myopia Focus launches customizable patient education tools for ECP websites

UK-based initiative’s Tool Creator enables clinical practice to create and embed interactive education tools directly into their digital interfaces.
Ametek Reichert integrates digital phoroptor into DigitalOptometrics' tele-optometry platform
Business

Ametek Reichert integrates digital phoroptor into DigitalOptometrics' tele-optometry platform

New partnership adds the SightCheck Digital Phoroptor to DO’s remote services for quick and practice-adaptable comprehensive refractions.
Bayer to acquire Perfuse Therapeutics, expanding ophthalmic pipeline
Business

Bayer to acquire Perfuse Therapeutics, expanding ophthalmic pipeline

Deal includes the biotech’s investigational sustained-release implant currently in phase 2 clinical trials for glaucoma and diabetic retinopathy.
Sun Pharma to buy Organon in $11.75B all-cash deal
Business

Sun Pharma to buy Organon in $11.75B all-cash deal

Closing in early 2027, the acquisition will position the Indian pharma company as a leader in the global biosimilar, established brands / branded generic spaces.
Leadership watch: Updates from Nanoscope, Topcon, Tenpoint, and TheiaLife
Business

Leadership watch: Updates from Nanoscope, Topcon, Tenpoint, and TheiaLife

Leadership changes are underway in the eyecare space—and we’ve got the latest.
Visionix–Revenio and Halma-Surgistar deals drive eye care consolidation
Business

Visionix–Revenio and Halma-Surgistar deals drive eye care consolidation

Halma’s bolt-on acquisition of Surgistar targets expansion of its surgical portfolio while Revenio will add Visionix’s Optovue line of OCT.
CareCredit report highlights gap between patient demand and vision care financing access
Business

CareCredit report highlights gap between patient demand and vision care financing access

National consumer study unveils costly barriers influencing patient decisions, prompting ECPs to initiate conversations early.
Biogen is purchasing Apellis
Business

Biogen is purchasing Apellis

With an estimated price tag of $5.6 billion, the acquisition includes the FDA-approved SYFOVRE.
Cencora to buy EyeSouth Partners' retina division in $1B deal
Business

Cencora to buy EyeSouth Partners' retina division in $1B deal

Deal will integrate the MCO’s retina business into Retina Consultants of America, expanding its nationwide network of affiliate retina practices.
Leadership watch: Qlaris, VSP, FFB, and SightGlass share updates
Business

Leadership watch: Qlaris, VSP, FFB, and SightGlass share updates

Leadership changes are underway in the eyecare space—and we’ve got the latest.